The strength of our study is that we have applied a range of analyses to explore the potential association between serum levels of IL-23 and IL-17 and anxiety severity and to evaluate the potential for these two cytokines to act as risk predictors of developing GAD. The gene discussed is IL17A; the disease is generalized anxiety disorder.